Obstructive Sleep Apnea and Hypertension

Hypertension

Volumn , Issue , 2005, Pages 765-773

  Gami, Apoor S ^a   Somers, Virend K ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60649121588     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50163-0     Document Type: Chapter

References (143)

1. Ohayon MM, Guilleminault C, Priest RG, et al. Is sleep-disordered breathing an independent risk factor for hypertension in the general population (13,057 subjects)?. J Psychosom Res 2000, 48:593-601.
2. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000, 160:2289-2295.
3. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
4. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: The Sleep Heart Health Study. Arch Intern Med 2002, 162:893-900.
5. Tishler PV, Larkin EK, Schluchter MD, et al. Incidence of sleep-disordered breathing in an urban adult population: The relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003, 289:2230-2237.
6. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003, 289:2560-2572.
7. Dart RA, Gregoire JR, Gutterman DD, et al. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest 2003, 123:244-260.
8. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000, 283:1829-1836.
9. Millman RP, Redline S, Carlisle CC, et al. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest 1991, 99:861-866.
10. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
11. Guilleminault C, Tilkian A, Dement WC The sleep apnea syndromes. Annu Rev Med 1976, 27:465-484.
12. Guilleminault C, Kim YD, Horita M, et al. Power spectral sleep EEG findings in patients with obstructive sleep apnea and upper airway resistance syndromes. Electroencephalogr Clin Neurophysiol Suppl 1999, 50:113-120.
13. Davies RJ, Stradling JR The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. Eur Respir J 1990, 3:509-514.
14. Katz I, Stradling J, Slutsky AS, et al. Do patients with obstructive sleep apnea have thick necks?. Am Rev Respir Dis 1990, 141:1228-1231.
15. Kushida CA, Efron B, Guilleminault C A predictive morpho-metric model for the obstructive sleep apnea syndrome. Ann Intern Med 1997, 127:581-587.
16. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of the American Academy of Sleep Medicine Task Force. Sleep 1999, 22:667-689.
17. Hornyak M, Cejnar M, Elam M, et al. Sympathetic muscle nerve activity during sleep in man. Brain 1991, 114(Pt 3):1281-1295.
18. Okada H, Iwase S, Mano T, et al. Changes in muscle sympathetic nerve activity during sleep in humans. Neurology 1991, 41:1961-1966.
19. Somers V, Dyken M, Mark A, et al. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993, 328:303-307.
20. Khatri IM, Freis ED Hemodynamic changes during sleep. J Appl Physiol 1967, 22:867-873.
21. Coccagna G, Mantovani M, Brignani F, et al. Laboratory note. Arterial pressure changes during spontaneous sleep in man. Electroencephalogr Clin Neurophysiol 1971, 31:277-281.
22. Miller JC, Helander M The 24 hour cycle and nocturnal depression of human cardiac output. Aviat Space Environ Med 1979, 50:1139-1144.
23. Coote JH Respiratory and circulatory control during sleep. J Exp Biol 1982, 100:223-244.
24. Furlan R, Guzzetti S, Crivellaro W, et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990, 81:537-547.
25. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
26. Tilkian AG, Guilleminault C, Schroeder JS, et al. Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med 1976, 85:714-719.
27. Motta J, Guilleminault C, Schroeder JS, et al. Tracheostomy and hemodynamic changes in sleep-inducing apnea. Ann Intern Med 1978, 89:454-458.
28. Portaluppi F, Provini F, Cortelli P, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997, 15:1227-1233.
29. Somers VK, Mark AL, Zavala DC, et al. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989, 67:2101-2106.
30. Somers VK, Mark AL, Zavala DC, et al. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989, 67:2095-2100.
31. Hedner J, Wilcox I, Laks L, et al. A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis 1992, 146:1240-1245.
32. Narkiewicz K, van de Borne PJ, Pesek CA, et al. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999, 99:1183-1189.
33. Somers V, Mark A, Abboud F Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension 1988, 11:608-612.
34. Somers V, Mark A, Abboud F Interaction of baroreceptor and chemoreceptor control of sympathetic nerve activity in normal humans. J Clin Invest 1991, 87:1953-1957.
35. Carlson JT, Hedner J, Elam M, et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993, 103:1763-1768.
36. Narkiewicz K, van de Borne PJ, Cooley RL, et al. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998, 98:772-776.
37. Hedner J, Ejnell H, Sellgren J, et al. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnea syndrome of pathogenetic importance for the development of hypertension?. J Hypertens 1988, 6:S529-S531.
38. Carlson J, Rangemark C, Hedner J Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996, 14:577-584.
39. Narkiewicz K, van de Borne P, Montano N, et al. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998, 97:943-945.
40. Narkiewicz K, Montano N, Cogliati C, et al. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998, 98.
41. Singh JP, Larson MG, Tsuji H, et al. Reduced heart rate variability and new-onset hypertension: Insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998, 32:293-297.
42. Ghuran A, Reid F, La Rovere MT, et al. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (the Autonomic Tone and Reflexes After Myocardial Infarction sub-study). Am J Cardiol 2002, 89:184-190.
43. La Rovere MT, Bigger JT, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998, 351:478-484.
44. Saul JP, Arai Y, Berger RD, et al. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1988, 61:1292-1299.
45. Kleiger RE, Miller JP, Bigger JT, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987, 59:256-262.
46. Frattola A, Parati G, Cuspidi C, et al. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993, 11:1133-1137.
47. Panza JA, Quyyumi AA, Brush JE, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990, 323:22-27.
48. Nieto FJ, Herrington DM, Redline S, et al. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004, 169:354-360.
49. Ip MS, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004, 169:348-353.
50. Kato M, Roberts-Thomson P, Phillips B Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000, 102:2607-2610.
51. Schulz R, Schmidt D, Blum A Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: Response to CPAP therapy. Thorax 2000, 55:1046-1051.
52. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000, 164:1997-1998.
53. Phillips B, Narkiewicz K, Pesek C, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertension 1999, 17:61-66.
54. Kanagy NL, Walker BR, Nelin LD Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001, 37:511-515.
55. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001, 104:3052-3056.
56. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000, 279:H234-H237.
57. Haynes WG, Morgan DA, Walsh SA, et al. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997, 100:270-278.
58. Shek E, Brands M, Hall J Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31:409-414.
59. Hatipoglu U, Rubinstein I Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003, 70:665-671.
60. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105:2462-2464.
61. Teramoto S, Yamamoto H, Ouchi Y Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 2003, 107:E40.
62. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85:1151-1158.
63. Ohga E, Nagase T, Tomita T, et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999, 87:10-14.
64. El-Solh AA, Mador MJ, Sikka P, et al. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002, 121:1541-1547.
65. Dyugovskaya L, Lavie P, Lavie L Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002, 165:934-939.
66. Dyugovskaya L, Lavie P, Lavie L Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 2003, 168:242-249.
67. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000, 162:566-570.
68. Lavie L, Lotan R, Hochberg I, et al. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome. Sleep 2003, 26:592-595.
69. Lavie L Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003, 7:35-51.
70. Schillaci G, Pirro M, Gemelli F, et al. Increased C-reactive protein concentrations in never-treated hypertension: The role of systolic and pulse pressures. J Hypertens 2003, 21:1841-1846.
71. Sesso HD, Buring JE, Rifai N, et al. C-reactive protein and the risk of developing hypertension. JAMA 2003, 290:2945-2951.
72. Wolk R, Shamsuzzaman AS, Somers VK Obesity, sleep apnea, and hypertension. Hypertension 2003.
73. Loube DI, Loube AA, Erman MK Continuous positive airway pressure treatment results in weight less in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 1997, 97:896-897.
74. Chin K, Shimizu K, Nakamura T, et al. Changes in intraabdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999, 100:706-712.
75. O'Donnell CP, Tankersley CG, Polotsky VP, et al. Leptin, obesity, and respiratory function. Respir Physiol 2000, 119:163-170.
76. Kiselak J, Clark M, Pera V, et al. The association between hypertension and sleep apnea in obese patients. Chest 1993, 104:775-780.
77. Garrison RJ, Kannel WB, Stokes J, et al. Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med 1987, 16:235-251.
78. Harman EM, Wynne JW, Block AJ The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. Chest 1982, 82:291-294.
79. Suratt PM, McTier RF, Findley LJ, et al. Effect of very-low-calorie diets with weight loss on obstructive sleep apnea. Am J Clin Nutr 1992, 56:182S-184S.
80. Pasquali R, Colella P, Cirignotta F, et al. Treatment of obese patients with obstructive sleep apnea syndrome (OSAS): Effect of weight loss and interference of otorhinolaryngoiatric pathology. Int J Obes 1990, 14:207-217.
81. Kansanen M, Vanninen E, Tuunainen A, et al. The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998, 18:377-385.
82. Dixon JB, O'Brien PE Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002, 184:51S-54S.
83. Browman CP, Sampson MG, Yolles SF, et al. Obstructive sleep apnea and body weight. Chest 1984, 85:435-438.
84. Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985, 103:850-855.
85. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981, 1:862-865.
86. Davies RJ, Stradling JR The efficacy of nasal continuous positive airway pressure in the treatment of obstructive sleep apnea syndrome is proven. Am J Respir Crit Care Med 2000, 161:1775-1776.
87. Montserrat JM, Ferrer M, Hernandez L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: A randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001, 164:608-613.
88. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised prospective parallel trial. Lancet 1999, 353:2100-2105.
89. Engleman HM, Wild MR Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 2003, 7:81-99.
90. Meurice JC, Dore P, Paquereau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994, 105:429-433.
91. Grote L, Hedner J, Grunstein R, et al. Therapy with nCPAP: Incomplete elimination of sleep related breathing disorder. Eur Respir J 2000, 16:921-927.
92. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68-73.
93. Malhotra A, Ayas NT, Epstein LJ The art and science of continuous positive airway pressure therapy in obstructive sleep apnea. Curr Opin Pulm Med 2000, 6:490-495.
94. Massie CA, Hart RW, Peralez K, et al. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999, 116:403-408.
95. Littner M, Hirshkowitz M, Davila D, et al. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. Sleep 2002, 25:143-147.
96. Berry RB, Parish JM, Hartse KM The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. An American Academy of Sleep Medicine review. Sleep 2002, 25:148-173.
97. Ferguson KA, Ono T, Lowe AA, et al. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996, 109:1269-1275.
98. O'Sullivan RA, Hillman DR, Mateljan R, et al. Mandibular advancement splint: An appliance to treat snoring and obstructive sleep apnea. Am J Respir Crit Care Med 1995, 151:194-198.
99. Schmidt-Nowara WW, Meade TE, Hays MB Treatment of snoring and obstructive sleep apnea with a dental orthosis. Chest 1991, 99:1378-1385.
100. Mehta A, Qian J, Petocz P, et al. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med 2001, 163:1457-1461.
101. Cartwright RD Predicting response to the tongue retaining device for sleep apnea syndrome. Arch Otolaryngol 1985, 111:385-388.
102. Sher AE, Schechtman KB, Piccirillo JF The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 1996, 19:156-177.
103. Heimer D, Scharf SM, Lieberman A, et al. Sleep apnea syndrome treated by repair of deviated nasal septum. Chest 1983, 84:184-185.
104. Larsson LH, Carlsson-Nordlander B, Svanborg E Four-year follow-up after uvulopalatopharyngoplasty in 50 unselected patients with obstructive sleep apnea syndrome. Laryngoscope 1994, 104:1362-1368.
105. Sugerman HJ, Fairman RP, Lindeman AK, et al. Gastroplasty for respiratory insufficiency of obesity. Ann Surg 1981, 193:677-685.
106. Victor DW, Sarmiento CF, Yanta M, et al. Obstructive sleep apnea in the morbidly obese. An indication for gastric bypass. Arch Surg 1984, 119:970-972.
107. Sugerman HJ, Fairman RP, Baron PL, et al. Gastric surgery for respiratory insufficiency of obesity. Chest 1986, 90:81-86.
108. Dixon JB, Schachter LM, O'Brien PE Sleep disturbance and obesity: Changes following surgically induced weight loss. Arch Intern Med 2001, 161:102-106.
109. Charuzi I, Lavie P, Peiser J, et al. Bariatric surgery in morbidly obese sleep-apnea patients: Short- and long-term follow-up. Am J Clin Nutr 1992, 55:594S-596S.
110. Peiser J, Lavie P, Ovnat A, et al. Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery. Ann Surg 1984, 199:112-115.
111. Mickelson SA Upper airway bypass surgery for obstructive sleep apnea syndrome. Otolaryngol Clin North Am 1998, 31:1013-1023.
112. Hedner J, Darpo B, Ejnell H, et al. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: Cardiovascular implications. Eur Respir J 1995, 8:222-229.
113. Moller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003, 16:274-280.
114. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: Effect of CPAP treatment. Eur Respir J 2003, 22:251-257.
115. Saarelainen S, Lahtela J, Kallonen E Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 1997, 6:146-147.
116. Sullivan CE, Issa FG, Berthon-Jones M, et al. Home treatment of obstructive sleep apnoea with continuous positive airway pressure applied through a nose-mask. Bull Eur Physiopathol Respir 1984, 20:49-54.
117. Peiris AN, Sothmann MS, Hoffmann RG, et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 1989, 110:867-872.
118. Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation 2003, 108:1718-1723.
119. Mayer J, Becker H, Brandenburg U, et al. Blood pressure and sleep apnea: Results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991, 79:84-92.
120. Jennum P, Wildschiodtz G, Christensen NJ, et al. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment. Am J Hypertens 1989, 2:847-852.
121. Wilcox I, Grunstein RR, Hedner JA, et al. Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 1993, 16:539-544.
122. Akashiba T, Kurashina K, Minemura H, et al. Daytime hypertension and the effects of short-term nasal continuous positive airway pressure treatment in obstructive sleep apnea syndrome. Intern Med 1995, 34:528-532.
123. Voogel AJ, van Steenwijk RP, Karemaker JM, et al. Effects of treatment of obstructive sleep apnea on circadian hemodynamics. J Auton Nerv Syst 1999, 77:177-183.
124. Faccenda JF, Mackay TW, Boon NA, et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001, 163:344-348.
125. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised parallel trial. Lancet 2002, 359:204-210.
126. Lavie P, Hoffstein V Sleep apnea syndrome: A possible contributing factor to resistant hypertension. Sleep 2001, 24:721-725.
127. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001, 19:2271-2277.
128. Isaksson H, Svanborg E Obstructive sleep apnea syndrome in male hypertensives, refractory to drug therapy. Nocturnal automatic blood pressure measurements-An aid to diagnosis?. Clin Exp Hypertens A 1991, 13:1195-1212.
129. Zelveian PA Possible contributing factors of sleep apnea syndrome to resistant hypertension. Sleep 2003, 26:12. author reply 12.
130. Logan AG, Tkacova R, Perlikowski SM, et al. Refractory hypertension and sleep apnoea: Effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003, 21:241-247.
131. Cloward TV, Walker JM, Farney RJ, et al. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003, 124:594-601.
132. Malone S, Liu PP, Hollo way R, et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: Effects of continuous positive airway pressure. Lancet 1991, 338:1480-1484.
133. Laaban JP, Pascal-Sebaoun S, Bloch E, et al. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002, 122:1133-1138.
134. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348:1233-1241.
135. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled Trial of Continuous Positive Airway Pressure in Obstructive Sleep Apnea and Heart Failure. Am J Respir Crit Care Med 2003.
136. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003, 107:2589-2594.
137. Peled N, Abinader EG, Pillar G, et al. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: Effects of continuous positive air pressure treatment. J Am Coll Cardiol 1999, 34:1744-1749.
138. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: Effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994, 79:1681-1685.
139. Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: A population-based study. J Intern Med 2001, 249:153-161.
140. Ip M, Lam B, Ng M, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:562-563.
141. Harsch IA, Pour Schahin S, Radespiel-Troger M, et al. CPAP treatment rapidly improves insulin sensitivity in patients with OSAS. Am J Respir Crit Care Med 2003.
142. Ip MS, Lam KS, Ho C, et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000, 118:580-586.
143. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165:677-682.